Lacosamide Tablets

Lacosamide, the active ingredient in Lacosamide Tablets, is an anticonvulsant presented as an oral tablet for systemic use. It is indicated for the treatment of partial‑onset seizures and is employed as adjunctive therapy in patients with epilepsy, helping to reduce seizure frequency in adult populations.

GNH USA supplies Lacosamide Tablets as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this EU‑marketed antiepileptic medication.

Lacosamide is an antiepileptic drug that acts on neuronal sodium channels to control seizure activity.

Partial‑onset seizures: Reduces seizure frequency when used as monotherapy or adjunctive therapy. Epilepsy (adjunctive therapy): Provides additional seizure control when combined with other antiepileptic drugs.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue

Serious or Rare Side Effects: - Cardiac conduction abnormalities such as PR‑interval prolongation - Severe skin reactions including Stevens‑Johnson syndrome - Suicidal thoughts or behavior

Before prescribing Lacosamide, clinicians should consider several safety aspects.

Renal impairment: Adjust therapy based on renal function. Pregnancy: Use only if potential benefit justifies potential risk to the fetus. Cardiac disease: Monitor ECG for PR‑interval changes. Concomitant CNS depressants: Observe for additive sedation. History of hypersensitivity: Avoid if prior allergic reaction to lacosamide. Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase lacosamide plasma levels. - Strong CYP3A4 inducers (e.g., carbamazepine) may reduce lacosamide efficacy. - Co‑administration with other sodium‑channel blockers may heighten CNS depression.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be reduced. - Alcohol: may enhance dizziness and sedation. - Antiplatelet agents: potential increase in bleeding risk.